Franck Schwartz has got a MD degree on 1989. After having practiced the medicine as a general practitioner for two years, he joined the Ipsen Group in 1992. He spent more than twenty years in the company where he held several QA roles spanning across the GCP and PV areas. He moved to the French Regulatory Agency as PV inspector before joining Novartis in 2014 as Senior Compliance Professional where he conducted a number of internal system audits across GCP, Pharmacovigilance and Computerised systems. He is now QA, Global Inspection, Intelligence Lead where he drives the production of metrics for GCP and PV areas and analyse the trending across these disciplines to interpret audit and inspection findings to ensure Global Drug Development maintains an industry-leading position in proactive continuous improvement related to changing regulatory landscape.